Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification

Objective: To analyze the potential mechanism of Mingjing granules in the treatment of wet age-related macular degeneration (wAMD) based on the research methods of network pharmacology and molecular docking approach and to provide a new reference for the currently limited treatment of wAMD. Material...

Full description

Bibliographic Details
Main Authors: Xiao-Yu Li, Li-Na Liang, Wei-Jun Zhang, Yun Gao, Qiang Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:World Journal of Traditional Chinese Medicine
Subjects:
Online Access:http://www.wjtcm.net/article.asp?issn=2311-8571;year=2024;volume=10;issue=1;spage=22;epage=32;aulast=Li
_version_ 1797221623142547456
author Xiao-Yu Li
Li-Na Liang
Wei-Jun Zhang
Yun Gao
Qiang Chen
author_facet Xiao-Yu Li
Li-Na Liang
Wei-Jun Zhang
Yun Gao
Qiang Chen
author_sort Xiao-Yu Li
collection DOAJ
description Objective: To analyze the potential mechanism of Mingjing granules in the treatment of wet age-related macular degeneration (wAMD) based on the research methods of network pharmacology and molecular docking approach and to provide a new reference for the currently limited treatment of wAMD. Materials and Methods: We searched TCMSP, GeneCards, OMIM, PharmGkb, TTD, and DrugBank database to screen the main active ingredients of Mingjing granules and their therapeutic targets of wAMD. The network of active components and targets was constructed using Cytoscape3.6.1 software, which was also used for the topological analysis of target genes. The network of Protein-Protein Interactions (PPI) was mapped using the String platform. We also used R language to do the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway for additional analysis. Molecular docking studies were finished by Chemoffice, Autodock, and Pymol. Finally, the efficacy of the Mingjing granules was examined in animal experiments, in which we used enzyme-linked immunosorbent assay to the contents of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) levels in peripheral blood. Results: Active compounds, including quercetin, lignocaine, and kaempferol, were found. PPI network analysis showed that tumor necrosis factor (TNF), MMP-9, epidermal growth factor (EGF), prostaglandin-endoperoxide synthase 2 (PTGS2), and caspase-3 (CASP3) were related to both Mingjing granules and wAMD. GO and KEGG pathway analysis showed that these targets were mainly involving lipids and atherosclerosis, TNF, and interleukin-17 (IL-17) signaling pathways. Docking studies suggested that quercetin and luteolin can fit in the binding pocket of four target proteins (CASP3, EGF, PTGS2, and TNF). In the vivo experiment, the Mingjing granules were found to be effective on the expression of VEGF and MMP-9 in peripheral blood. Conclusions: This study initially reveals the multi-constituent, multi-target, and multi-pathway mechanism of action of Mingjing granules in the treatment of wAMD and implies the inhibition of choroidal neovascularization may be related to the expression of VEGF and MMP-9.
first_indexed 2024-04-24T13:08:22Z
format Article
id doaj.art-4e9e7d2b99ff43d8958e21512a70ba3e
institution Directory Open Access Journal
issn 2311-8571
language English
last_indexed 2024-04-24T13:08:22Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series World Journal of Traditional Chinese Medicine
spelling doaj.art-4e9e7d2b99ff43d8958e21512a70ba3e2024-04-05T05:28:59ZengWolters Kluwer Medknow PublicationsWorld Journal of Traditional Chinese Medicine2311-85712024-01-01101223210.4103/wjtcm.wjtcm_39_23Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verificationXiao-Yu LiLi-Na LiangWei-Jun ZhangYun GaoQiang ChenObjective: To analyze the potential mechanism of Mingjing granules in the treatment of wet age-related macular degeneration (wAMD) based on the research methods of network pharmacology and molecular docking approach and to provide a new reference for the currently limited treatment of wAMD. Materials and Methods: We searched TCMSP, GeneCards, OMIM, PharmGkb, TTD, and DrugBank database to screen the main active ingredients of Mingjing granules and their therapeutic targets of wAMD. The network of active components and targets was constructed using Cytoscape3.6.1 software, which was also used for the topological analysis of target genes. The network of Protein-Protein Interactions (PPI) was mapped using the String platform. We also used R language to do the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway for additional analysis. Molecular docking studies were finished by Chemoffice, Autodock, and Pymol. Finally, the efficacy of the Mingjing granules was examined in animal experiments, in which we used enzyme-linked immunosorbent assay to the contents of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) levels in peripheral blood. Results: Active compounds, including quercetin, lignocaine, and kaempferol, were found. PPI network analysis showed that tumor necrosis factor (TNF), MMP-9, epidermal growth factor (EGF), prostaglandin-endoperoxide synthase 2 (PTGS2), and caspase-3 (CASP3) were related to both Mingjing granules and wAMD. GO and KEGG pathway analysis showed that these targets were mainly involving lipids and atherosclerosis, TNF, and interleukin-17 (IL-17) signaling pathways. Docking studies suggested that quercetin and luteolin can fit in the binding pocket of four target proteins (CASP3, EGF, PTGS2, and TNF). In the vivo experiment, the Mingjing granules were found to be effective on the expression of VEGF and MMP-9 in peripheral blood. Conclusions: This study initially reveals the multi-constituent, multi-target, and multi-pathway mechanism of action of Mingjing granules in the treatment of wAMD and implies the inhibition of choroidal neovascularization may be related to the expression of VEGF and MMP-9.http://www.wjtcm.net/article.asp?issn=2311-8571;year=2024;volume=10;issue=1;spage=22;epage=32;aulast=Liexperimental verificationmingjing granulesmolecular dockingnetwork pharmacologywet age-related macular degeneration
spellingShingle Xiao-Yu Li
Li-Na Liang
Wei-Jun Zhang
Yun Gao
Qiang Chen
Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
World Journal of Traditional Chinese Medicine
experimental verification
mingjing granules
molecular docking
network pharmacology
wet age-related macular degeneration
title Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
title_full Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
title_fullStr Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
title_full_unstemmed Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
title_short Mechanism of mingjing granules in treating wet age-related macular degeneration based on network pharmacology and experimental verification
title_sort mechanism of mingjing granules in treating wet age related macular degeneration based on network pharmacology and experimental verification
topic experimental verification
mingjing granules
molecular docking
network pharmacology
wet age-related macular degeneration
url http://www.wjtcm.net/article.asp?issn=2311-8571;year=2024;volume=10;issue=1;spage=22;epage=32;aulast=Li
work_keys_str_mv AT xiaoyuli mechanismofmingjinggranulesintreatingwetagerelatedmaculardegenerationbasedonnetworkpharmacologyandexperimentalverification
AT linaliang mechanismofmingjinggranulesintreatingwetagerelatedmaculardegenerationbasedonnetworkpharmacologyandexperimentalverification
AT weijunzhang mechanismofmingjinggranulesintreatingwetagerelatedmaculardegenerationbasedonnetworkpharmacologyandexperimentalverification
AT yungao mechanismofmingjinggranulesintreatingwetagerelatedmaculardegenerationbasedonnetworkpharmacologyandexperimentalverification
AT qiangchen mechanismofmingjinggranulesintreatingwetagerelatedmaculardegenerationbasedonnetworkpharmacologyandexperimentalverification